Form 4 for SLDB Solid Biosciences Inc.
Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-14 · accession 0001209191-22-018883 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-15 | 2022-03-14 | SLDB | Schneider Joel Solomon Zev | COO | S - Sale | $1.10 | -30.5K | 236.3K | -11% | -$33.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-14 | S | D | 15,232 | $1.10 | 251,542 | D | — | — | (F1) This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1). (F2) Reflects a correction as to the number of securities previously reported in Column 5 of Table I due to an arithmetical error. |
| 2 | Common | Common Stock | 2022-03-14 | S | D | 15,272 | $1.10 | 236,270 | D | — | — | (F1) This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1). |